Keywords
Virus de inmunodeficiencia humana (VIH)
Síndrome de inmunodeficiencia adquirida (SIDA)
Infecciones de repetición
Tuberculosis
Linfadenopatía
How to Cite
Abstract
Objective: To determine the clinical and epidemiological characteristics and factors associated with immunosuppression in children living with HIV.
Methods: Observational, analytical, cross-sectional study of patients treated at the Outpatient Center for the Prevention and Care of AIDS and Sexually Transmitted Infections in the State of Puebla. Statistical analysis: percentages, frequencies, means, standard deviation and medians; Inferential analysis: c2 and univariate logistic regression. Statistical Package, for the Social Sciences 24.
Results: A total of 83 patients aged 0 to 17 years (mean 7 years; SD ± 6.3) were selected, with an average age at diagnosis of 2.6 years. Vertical transmission was found in 90% of cases; women 47% and men 53%. The most frequent diseases were recurrent infections, lymphadenopathy, diarrhea; four cases of tuberculosis were reported, malnutrition 35%. Clinical category: N 25%, A 66%. Immunological category: 1-72%, 2-13%. Factors associated with immunosuppression were vertical transmission (p < 0.008) and CD4 level (p < 0.007).
Conclusions: Knowing the characteristics that describe pediatric HIV/AIDS, its clinical presentation, and its limitations, may guide to install improvements in care and follow-up, improving the prognosis of children.
Keywords: Immunosuppression; Human immunodeficiency virus (HIV); Acquired Immunodeficiency Syndrome (AIDS); Recurrent infections; Tuberculosis; Lymphadenopathy.
References
1. Martínez MI, Berzosa A, Navarro ML, Fortuny GC. Infección por el virus de la inmunodeficiencia humana (VIH) en Pediatría. Protoc Diagn Ter Pediatr 2023; 2: 387-400.
2. ONUSIDA. Hoja informativa -Últimas estadísticas sobre el estado de la epidemia de sida. Ginebra: UNAIDS; 2024. https://www.unaids.org/es/resources/fact-sheet
3. CENSIDA. Epidemiología Registro Nacional de casos de VIH y sida. México: CENSIDA; 2024. https://www.gob.mx/censida/documentos/epidemiologia-registro-nacional-de-casos-de-sida
4. Vallejo BÁ, Lobo AH, García IC, et al. Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort. BMC Infect Dis 2024; 24 (1): 222. doi: 10.1186/s12879-024-09091-9
5. World Health Organization. (2007). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization. https://iris.who.int/handle/10665/43699
6. Dutschke A, Jensen MM, Nanque JP, et al. Clinical presentations and outcomes of HIV-1 and HIV-2 among infected children in Guinea-Bissau: a nationwide study. Public Health 2024; 230: 38-44. doi: 10.1016/j.puhe.2024.02.008
7. 7.- Lala MM. The 'pulmonary diseases spectrum' in HIV infected children. Indian J Tuberc 2023; 70 (Suppl 1): S49-S58. doi: 10.1016/j.ijtb.2023.09.002
8. CENSIDA. Guía de Manejo Antirretroviral de las Personas con VIH-México 2021. México: CENSIDA; 2024. https://www.gob.mx/censida/documentos/guia-de-manejo-antirretroviral-de-las-personas-con-vih-mexico-2021-297710
9. Palacio-Mejía LS, Hernández-Ávila JE, Molina-Vélez D, et al. Trends in Mortality by HIV/AIDS in Children in Mexico: Towards the Elimination of Mother-To-Child Transmission. Arch Med Res 2021; 52 (7): 746-754. doi: 10.1016/j.arcmed.2021.04.008
10. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 2013; 310 (20): 2191-2194. Doi 10.1001/jama.2013.281053
11. Mapera E, Fina JP, Mabiala JB, Ngwala LP, Nzaumvila D. Clinico-epidemiological profile of children living with HIV/AIDS managed at Heal Africa Hospital, Goma, Democratic Republic of the Congo. Afr Health Sci 2022; 22 (4): 435-442. doi: 10.4314/ahs.v22i4.49
12. Cardenas MC, Farnan S, Hamel BL, Mejia-Plazas MC, et al. Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far. Viruses 2023; 15 (4): 849. https://doi.org/10.3390/v15040849
13. Miguel CV, Henderson SL. Updates in the Approach to Pediatric HIV Care and Prevention Curr Treat Opt Pediatr 2023; 9 (4): 165-184. doi: 10.1007/s40746-023-00278-x
14. Hernanz-Lobo A, Ruiz Saez B, Carrasco García I, et al. New diagnosis of mother-to-child transmission of HIV in 8 Latin-American countries during 2018. BMC Infect Dis 2022; 22 (1): 347. doi: 10.1186/s12879-022-07311-8
15. CDC. 1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age. USA: MMWR; 2001. https://www.cdc.gov/MMWr/preview/mmwrhtml/00032890.htm
16. Biyazin Y, Wondwossen K, Wubie AB, Getachew M, et al. Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals. J Pharm Policy Pract 2022; 15 (1): 48. doi: 10.1186/s40545-022-00448-6
17. Oumer A, Kubsa ME, Mekonnen BA. Malnutrition as predictor of survival from anti-retroviral treatment among children living with HIV/AIDS in Southwest Ethiopia: survival analysis. BMC Pediatr 2019; 19 (1): 474. doi: 10.1186/s12887-019-1823-x
18. Gemechu J, Gebremichael B, Tesfaye T, Seyum A, et al. Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study. Arch Public Health 2022; 80 (1): 11. doi: 10.1186/s13690-021-00713-1
19. Figueroa MLP, Xochihua DL, Figueroa DR. Características clínicas y epidemiológicas de pacientes pediátricos con infección por VIH/SIDA: informe de 124 pacientes. Bol Med Hosp Infant Mex 2001; 58: 771-779.
20. Khetan P, Liu Y, Dhummakupt A, Persaud D. Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays. Viruses 2022; 14 (12): 2608. https://doi.org/10.3390/v14122608
21. Berendam SJ, Nelson AN, Yagnik B, et al. Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure. Front Immunol 2022; 13: 885272. doi: 10.3389/fimmu.2022.885272
22. Gwadu AA, Tegegne AS. Determinants of CD4 count and risk for death of HIV infected children under ART. Sci Rep 2022; 12 (1): 6867. doi: 10.1038/s41598-022-10880-y
23. Chinunga TT, Chahroudi A, Ribeiro SP. Pediatric immunotherapy and HIV control. Curr Opin HIV AIDS 2024; 19 (4): 201-211. doi: 10.1097/COH.0000000000000857.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 Revista Alergia México